Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical Performance

 Insufficient evidence exists to guide the long-term pharmacological management of Huntington’s disease (HD) although most current interventions rely on symptomatic management. The effect of many frontline treatments on potential endpoints for HD clinical trials remains unknown. Our objective was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Keogh, Ruth, Frost, Chris, Owen, Gail, Daniel, Rhian M., Langbehn, Doug R., Leavitt, Blair, Durr, Alexandra, Roos, Raymund A.C., Landwehrmeyer, G. Bernhard, Reilmann, Ralf, Borowsky, Beth, Stout, Julie, Craufurd, David, Tabrizi, Sarah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718719/
https://www.ncbi.nlm.nih.gov/pubmed/26819833
http://dx.doi.org/10.1371/currents.hd.8060298fac1801b01ccea6acc00f97cb

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718719/
https://www.ncbi.nlm.nih.gov/pubmed/26819833
http://dx.doi.org/10.1371/currents.hd.8060298fac1801b01ccea6acc00f97cb

Ejemplares similares